DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Mycobacterial nicotinate mononucleotide adenylyltransferase: Structure, mechanism, and implications for drug discovery

Abstract

Nicotinate mononucleotide adenylyltransferase NadD is an essential enzyme in the biosynthesis of the NAD cofactor, which has been implicated as a target for developing new antimycobacterial therapies. Here we report the crystal structure of Mycobacterium tuberculosis NadD (MtNadD) at a resolution of 2.4 Å. A remarkable new feature of the MtNadD structure, compared with other members of this enzyme family, is a 310 helix that locks the active site in an over-closed conformation. As a result, MtNadD is rendered inactive as it is topologically incompatible with substrate binding and catalysis. Directed mutagenesis was also used to further dissect the structural elements that contribute to the interactions of the two MtNadD substrates, i.e. ATP and nicotinic acid mononucleotide (NaMN). For inhibitory profiling of partially active mutants and wild type MtNadD, we used a small molecule inhibitor of MtNadD with moderate affinity (Ki ~ 25 μM) and antimycobacterial activity (MIC80) ~ 40-80 μM). This analysis revealed interferences with some of the residues in the NaMN binding subsite consistent with the competitive inhibition observed for the NaMN substrate (but not ATP). A detailed steady-state kinetic analysis of MtNadD suggests that ATP must first bind to allow efficient NaMN binding and catalysis. This sequentialmore » mechanism is consistent with the requirement of transition to catalytically competent (open) conformation hypothesized from structural modeling. A possible physiological significance of this mechanism is to enable the down-regulation of NAD synthesis under ATP-limiting dormancy conditions. Lastly, these findings point to a possible new strategy for designing inhibitors that lock the enzyme in the inactive over-closed conformation.« less

Authors:
 [1];  [2];  [3];  [1];  [4];  [1];  [1];  [5];  [2];  [1]
  1. Sanford-Burnham Medical Research Institute, La Jolla, CA (United States)
  2. Vertex Pharmaceuticals Inc., Boston, MA (United States)
  3. Polytechnic Univ. of Marche, Ancona (Italy)
  4. Russian Academy of Sciences, Moscow (Russia)
  5. Harvard School of Public Health, Boston, MA (United States)
Publication Date:
Research Org.:
Univ. of California, Berkeley, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1347693
Grant/Contract Number:  
AC02-05CH11231
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Biological Chemistry
Additional Journal Information:
Journal Volume: 290; Journal Issue: 12; Journal ID: ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular Biology
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; 60 APPLIED LIFE SCIENCES; enzyme inhibitor; enzyme structure; NAD biosynthesis; protein engineering; protein targeting

Citation Formats

Rodionova, Irina A., Zuccola, Harmon J., Sorci, Leonardo, Aleshin, Alexander E., Kazanov, Marat D., Ma, Chen -Ting, Sergienko, Eduard, Rubin, Eric J., Locher, Christopher P., and Osterman, Andrei L. Mycobacterial nicotinate mononucleotide adenylyltransferase: Structure, mechanism, and implications for drug discovery. United States: N. p., 2015. Web. doi:10.1074/jbc.m114.628016.
Rodionova, Irina A., Zuccola, Harmon J., Sorci, Leonardo, Aleshin, Alexander E., Kazanov, Marat D., Ma, Chen -Ting, Sergienko, Eduard, Rubin, Eric J., Locher, Christopher P., & Osterman, Andrei L. Mycobacterial nicotinate mononucleotide adenylyltransferase: Structure, mechanism, and implications for drug discovery. United States. https://doi.org/10.1074/jbc.m114.628016
Rodionova, Irina A., Zuccola, Harmon J., Sorci, Leonardo, Aleshin, Alexander E., Kazanov, Marat D., Ma, Chen -Ting, Sergienko, Eduard, Rubin, Eric J., Locher, Christopher P., and Osterman, Andrei L. Wed . "Mycobacterial nicotinate mononucleotide adenylyltransferase: Structure, mechanism, and implications for drug discovery". United States. https://doi.org/10.1074/jbc.m114.628016. https://www.osti.gov/servlets/purl/1347693.
@article{osti_1347693,
title = {Mycobacterial nicotinate mononucleotide adenylyltransferase: Structure, mechanism, and implications for drug discovery},
author = {Rodionova, Irina A. and Zuccola, Harmon J. and Sorci, Leonardo and Aleshin, Alexander E. and Kazanov, Marat D. and Ma, Chen -Ting and Sergienko, Eduard and Rubin, Eric J. and Locher, Christopher P. and Osterman, Andrei L.},
abstractNote = {Nicotinate mononucleotide adenylyltransferase NadD is an essential enzyme in the biosynthesis of the NAD cofactor, which has been implicated as a target for developing new antimycobacterial therapies. Here we report the crystal structure of Mycobacterium tuberculosis NadD (MtNadD) at a resolution of 2.4 Å. A remarkable new feature of the MtNadD structure, compared with other members of this enzyme family, is a 310 helix that locks the active site in an over-closed conformation. As a result, MtNadD is rendered inactive as it is topologically incompatible with substrate binding and catalysis. Directed mutagenesis was also used to further dissect the structural elements that contribute to the interactions of the two MtNadD substrates, i.e. ATP and nicotinic acid mononucleotide (NaMN). For inhibitory profiling of partially active mutants and wild type MtNadD, we used a small molecule inhibitor of MtNadD with moderate affinity (Ki ~ 25 μM) and antimycobacterial activity (MIC80) ~ 40-80 μM). This analysis revealed interferences with some of the residues in the NaMN binding subsite consistent with the competitive inhibition observed for the NaMN substrate (but not ATP). A detailed steady-state kinetic analysis of MtNadD suggests that ATP must first bind to allow efficient NaMN binding and catalysis. This sequential mechanism is consistent with the requirement of transition to catalytically competent (open) conformation hypothesized from structural modeling. A possible physiological significance of this mechanism is to enable the down-regulation of NAD synthesis under ATP-limiting dormancy conditions. Lastly, these findings point to a possible new strategy for designing inhibitors that lock the enzyme in the inactive over-closed conformation.},
doi = {10.1074/jbc.m114.628016},
journal = {Journal of Biological Chemistry},
number = 12,
volume = 290,
place = {United States},
year = {Wed Jan 28 00:00:00 EST 2015},
month = {Wed Jan 28 00:00:00 EST 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 17 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

WHO's 2013 global report on tuberculosis: successes, threats, and opportunities
journal, November 2013


Mycobacterium tuberculosis : success through dormancy
journal, May 2012


Targeting Dormant Bacilli to Fight Tuberculosis
journal, January 2013

  • Fattorini, Lanfranco; Piccaro, Giovanni; Mustazzolu, Alessandro
  • Mediterranean Journal of Hematology and Infectious Diseases, Vol. 5, Issue 1
  • DOI: 10.4084/mjhid.2013.072

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
journal, April 2014

  • Zumla, Alimuddin I.; Gillespie, Stephen H.; Hoelscher, Michael
  • The Lancet Infectious Diseases, Vol. 14, Issue 4
  • DOI: 10.1016/S1473-3099(13)70328-1

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
journal, January 2005


Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase
journal, August 2011


Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
journal, February 2014

  • Koul, Anil; Vranckx, Luc; Dhar, Neeraj
  • Nature Communications, Vol. 5, Issue 1
  • DOI: 10.1038/ncomms4369

A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence
journal, November 2013

  • Kim, J. -H.; O'Brien, K. M.; Sharma, R.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 47
  • DOI: 10.1073/pnas.1315860110

Biosynthesis and Recycling of Nicotinamide Cofactors in Mycobacterium tuberculosis: AN ESSENTIAL ROLE FOR NAD IN NONREPLICATING BACILLI
journal, May 2008

  • Boshoff, Helena I. M.; Xu, Xia; Tahlan, Kapil
  • Journal of Biological Chemistry, Vol. 283, Issue 28
  • DOI: 10.1074/jbc.M800694200

Complexes of Bacterial Nicotinate Mononucleotide Adenylyltransferase with Inhibitors: Implication for Structure-Based Drug Design and Improvement
journal, July 2010

  • Huang, Nian; Kolhatkar, Rohit; Eyobo, Yvonne
  • Journal of Medicinal Chemistry, Vol. 53, Issue 14
  • DOI: 10.1021/jm100377f

Genomics-driven Reconstruction of Acinetobacter NAD Metabolism: INSIGHTS FOR ANTIBACTERIAL TARGET SELECTION
journal, October 2010

  • Sorci, Leonardo; Blaby, Ian; De Ingeniis, Jessica
  • Journal of Biological Chemistry, Vol. 285, Issue 50
  • DOI: 10.1074/jbc.M110.185629

Quinolinate Salvage and Insights for Targeting NAD Biosynthesis in Group A Streptococci
journal, November 2012

  • Sorci, L.; Blaby, I. K.; Rodionova, I. A.
  • Journal of Bacteriology, Vol. 195, Issue 4
  • DOI: 10.1128/JB.02002-12

Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis
journal, February 2009

  • Sorci, L.; Martynowski, D.; Rodionov, D. A.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 9
  • DOI: 10.1073/pnas.0811718106

Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria
journal, February 2014

  • Rodionova, Irina A.; Schuster, Brian M.; Guinn, Kristine M.
  • mBio, Vol. 5, Issue 1
  • DOI: 10.1128/mBio.00747-13

Glutamine versus Ammonia Utilization in the NAD Synthetase Family
journal, June 2012


Regulation of active site coupling in glutamine-dependent NAD+ synthetase
journal, March 2009

  • LaRonde-LeBlanc, Nicole; Resto, Melissa; Gerratana, Barbara
  • Nature Structural & Molecular Biology, Vol. 16, Issue 4
  • DOI: 10.1038/nsmb.1567

Signalling Inhibitors Against Mycobacterium tuberculosis – Early Days of a New Therapeutic Concept in Tuberculosis
journal, November 2008


Kinetic and X-Ray Structural Evidence for Negative Cooperativity in Substrate Binding to Nicotinate Mononucleotide Adenylyltransferase (NMAT) from Bacillus anthracis
journal, January 2009

  • Sershon, Valerie C.; Santarsiero, Bernard D.; Mesecar, Andrew D.
  • Journal of Molecular Biology, Vol. 385, Issue 3
  • DOI: 10.1016/j.jmb.2008.10.037

Crystal Structure of Nicotinic Acid Mononucleotide Adenylyltransferase from Staphyloccocus aureus: Structural Basis for NaAD Interaction in Functional Dimer
journal, July 2006

  • Han, Seungil; Forman, Michael D.; Loulakis, Pat
  • Journal of Molecular Biology, Vol. 360, Issue 4
  • DOI: 10.1016/j.jmb.2006.05.055

Subcellular Compartmentation and Differential Catalytic Properties of the Three Human Nicotinamide Mononucleotide Adenylyltransferase Isoforms
journal, August 2005

  • Berger, Felicitas; Lau, Corinna; Dahlmann, Mathias
  • Journal of Biological Chemistry, Vol. 280, Issue 43
  • DOI: 10.1074/jbc.M508660200

Domain Organization and a Protease-Sensitive Loop in Eukaryotic Ornithine Decarboxylase
journal, October 1995

  • Osterman, Andrei L.; Lueder, Deirdre V.; Quick, Mary
  • Biochemistry, Vol. 34, Issue 41
  • DOI: 10.1021/bi00041a021

Archaeal Shikimate Kinase, a New Member of the GHMP-Kinase Family
journal, January 2001


Data processing and analysis with the autoPROC toolbox
journal, March 2011

  • Vonrhein, Clemens; Flensburg, Claus; Keller, Peter
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444911007773

REFMAC 5 for the refinement of macromolecular crystal structures
journal, March 2011

  • Murshudov, Garib N.; Skubák, Pavol; Lebedev, Andrey A.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444911001314

Overview of the CCP 4 suite and current developments
journal, March 2011

  • Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910045749

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery
journal, September 2004


Crystal Structures of E. coli Nicotinate Mononucleotide Adenylyltransferase and Its Complex with Deamido-NAD
journal, January 2002


Identification of Nicotinamide Mononucleotide Deamidase of the Bacterial Pyridine Nucleotide Cycle Reveals a Novel Broadly Conserved Amidohydrolase Family
journal, September 2011

  • Galeazzi, Luca; Bocci, Paola; Amici, Adolfo
  • Journal of Biological Chemistry, Vol. 286, Issue 46
  • DOI: 10.1074/jbc.M111.275818

Characterization of bacterial NMN deamidase as a Ser/Lys hydrolase expands diversity of serine amidohydrolases
journal, February 2014


The scent of Mycobacterium tuberculosis – Part II breath
journal, July 2009


Works referencing / citing this record:

High-resolution crystal structure of human asparagine synthetase enables analysis of inhibitor binding and selectivity
journal, September 2019


The Mycobacterium tuberculosis Pup-proteasome system regulates nitrate metabolism through an essential protein quality control pathway
journal, February 2019

  • Becker, Samuel H.; Jastrab, Jordan B.; Dhabaria, Avantika
  • Proceedings of the National Academy of Sciences, Vol. 116, Issue 8
  • DOI: 10.1073/pnas.1819468116

Molecular basis of human asparagine synthetase inhibitor specificity
posted_content, September 2018

  • Zhu, Wen; Radadiya, Ashish; Bisson, Claudine
  • BioRxiv
  • DOI: 10.1101/428508